Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Peter Voorhees, MD
University of North Carolina, Chapel Hill
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
336 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Oncology and Hematology Llc
Anchorage, Alaska, United States
- Alaska Regional Hospital
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Associates in Radiation Medicine
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Delaware Clinical and Laboratory Physicians Pa
Newark, Delaware, United States
- Helen F Graham Cancer Center
Newark, Delaware, United States
- Medical Oncology Hematology Consultants Pa
Newark, Delaware, United States
- Beebe Health Campus
Rehoboth Beach, Delaware, United States
- Nanticoke Memorial Hospital
Seaford, Delaware, United States
- Christiana Care Health System-Wilmington Hospital
Wilmington, Delaware, United States
- Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
- Memorial Health University Medical Center
Savannah, Georgia, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Saint Luke'S Mountain States Tumor Institute
Boise, Idaho, United States
- Saint Alphonsus Cancer Care Center-Caldwell
Caldwell, Idaho, United States
- Kootenai Medical Center
Coeur d'Alene, Idaho, United States
- Walter Knox Memorial Hospital
Emmett, Idaho, United States
- Saint Luke'S Mountain States Tumor Institute - Fruitland
Fruitland, Idaho, United States
- Idaho Urologic Institute-Meridian
Meridian, Idaho, United States
- Saint Luke'S Mountain States Tumor Institute - Meridian
Meridian, Idaho, United States
- Saint Alphonsus Medical Center-Nampa
Nampa, Idaho, United States
- Saint Luke'S Mountain States Tumor Institute - Nampa
Nampa, Idaho, United States
- Kootenai Cancer Center
Post Falls, Idaho, United States
- Kootenai Cancer Clinic
Sandpoint, Idaho, United States
- Saint Luke'S Mountain States Tumor Institute-Twin Falls
Twin Falls, Idaho, United States
- Rush - Copley Medical Center
Aurora, Illinois, United States
- Illinois Cancercare-Bloomington
Bloomington, Illinois, United States
- Saint Joseph Medical Center
Bloomington, Illinois, United States
- Illinois Cancercare-Canton
Canton, Illinois, United States
- Memorial Hospital of Carbondale
Carbondale, Illinois, United States
- Sih Cancer Institute
Carterville, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2014
- Primary completion
- 1 Dec 2021
- Completion
- —
- Last update posted
- 1 Dec 2023
- Registered enrollment
- 118
- Registry id
- NCT02004275
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.